McKesson (NYSE:MCK) Issues FY25 Earnings Guidance

McKesson (NYSE:MCK) updated its FY25 earnings guidance on Thursday. The company provided earnings per share guidance of $31.75-$32.55 for the period, compared to the consensus earnings per share estimate of $32.19. McKesson also updated its Q2 guidance to $6.70-$7.00 EPS.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. StockNews.com cut McKesson from a strong-buy rating to a buy rating in a research note on Friday, August 9th. Bank of America boosted their price objective on shares of McKesson from $590.00 to $670.00 and gave the stock a buy rating in a research report on Tuesday, June 25th. Argus raised their target price on shares of McKesson from $570.00 to $670.00 and gave the company a buy rating in a research report on Monday, June 24th. Robert W. Baird cut their price target on shares of McKesson from $694.00 to $671.00 and set an outperform rating on the stock in a research report on Thursday, August 8th. Finally, Mizuho raised their price objective on McKesson from $540.00 to $570.00 and gave the company a neutral rating in a report on Thursday, August 8th. Two analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of Moderate Buy and a consensus target price of $624.93.

McKesson Trading Down 2.1 %

MCK opened at $504.17 on Friday. The stock’s fifty day simple moving average is $574.75 and its 200 day simple moving average is $557.64. McKesson has a 1-year low of $412.64 and a 1-year high of $637.51. The stock has a market cap of $65.51 billion, a PE ratio of 22.53, a price-to-earnings-growth ratio of 1.29 and a beta of 0.44.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, August 7th. The company reported $7.88 earnings per share for the quarter, beating the consensus estimate of $7.21 by $0.67. The company had revenue of $79.28 billion for the quarter, compared to analyst estimates of $82.53 billion. McKesson had a net margin of 0.94% and a negative return on equity of 242.57%. The company’s revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the firm earned $7.27 earnings per share. Equities analysts forecast that McKesson will post 32.14 earnings per share for the current year.

McKesson Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 1st. Stockholders of record on Monday, September 2nd will be issued a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.56%. The ex-dividend date is Friday, August 30th. This is a boost from McKesson’s previous quarterly dividend of $0.62. McKesson’s payout ratio is currently 12.69%.

Insider Transactions at McKesson

In related news, CEO Brian S. Tyler sold 3,753 shares of the business’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $561.10, for a total value of $2,105,808.30. Following the completion of the sale, the chief executive officer now directly owns 78,586 shares in the company, valued at approximately $44,094,604.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, EVP Leann B. Smith sold 600 shares of the business’s stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $585.53, for a total value of $351,318.00. Following the completion of the sale, the executive vice president now directly owns 2,022 shares in the company, valued at $1,183,941.66. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Brian S. Tyler sold 3,753 shares of the firm’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $561.10, for a total value of $2,105,808.30. Following the transaction, the chief executive officer now owns 78,586 shares in the company, valued at approximately $44,094,604.60. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 11,859 shares of company stock worth $6,986,810. Company insiders own 0.11% of the company’s stock.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.